Showing results (371-380 of 603) with videos related to
Sort By:
Pageof 61
Nurse Education Today|December 5, 2022
A qualitative exploration of undergraduate nursing students' experience of emotional safety for learning during their clinical practiceAlison Steven, Silvia Rossi, Nicoletta Dasso, et al.EFSA Journal. European Food Safety Authority|September 3, 2020
Lumpy skin disease epidemiological report IV: data collection and analysis, Paolo Calistri, Kris De Clercq, et al.Plos One|December 31, 2009
Identification and developmental expression of Xenopus laevis SUMO proteasesYonggang Wang, Debaditya Mukhopadhyay, Smita Mathew, et al.International Journal of Tissue Reactions|January 1, 1991
Breast cancer metastases of the urinary bladderP Rigatti, L Broglia, F Montorsi, et al.Bjpsych Open|May 10, 2022
Key questions: research priorities for student mental healthKatie Sampson, Michael Priestley, Alyson L Dodd, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?Paolo G Gobbi, Luca Baldini, Chiara Broglia, et al.The Pediatric Infectious Disease Journal|November 1, 1989
Detection of circulating antibodies to purified protein derivative by enzyme-linked immunosorbent assay: its potential for the rapid diagnosis of tuberculosisL Barrera, I Miceli, V Ritacco, et al.Plos One|August 29, 2009
Human condensin function is essential for centromeric chromatin assembly and proper sister kinetochore orientationAlexander Samoshkin, Alexei Arnaoutov, Lars E T Jansen, et al.Journal of Preventive Medicine and Hygiene|March 3, 2025
Basing patient safety education on real student experience: development of a multinational simulation scenarioAnnamaria Bagnasco, Silvia Rossi, Nicoletta Dasso, et al.Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.Pageof 61